Abstract
Cisplatin drug is one of platinum compounds and it is in common use world wide for the treatment of a variety of human neoplasms. However in high doses it can produceundesirable toxic side effects on liver, so in this study we investigated whether Thymoqunion has protective effect on hepatotoxicity induced by cisplatin or not. Four equal-sized groups(four rats each) of adult female rats with colon cancer induced in two group unless control group by used azoxymethane carcinogen were used as (control group, AOM group cisplatin group, Thymoqunion group (TQ)). It was detected for tumor by measuring the concentration CEA in serum, it was observed significant increase (P<0.05) when injected article carcinogen totals compared with the control group. when the transaction ad these two articles focusing decreased response to treatment user. Histological examination of livers were carried out using light microscopy. Results showed that cisplatin produced histopathological changes in liver tissue, congestion and expansion of central veins, dilatation and congestion of sinusoids, with necrosis of liver cells and endothelial cells, severe fatty infiltration and necrotic foci in large areas from liver cells, congestion of sinusoids, while Thymoqunion not appear any side effect on liver tissue
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
